Xcellbio and AmplifyBio News and Resources

Xcellbio and AmplifyBio, a contract development and manufacturing organisation (CDMO), have announced a partnership aimed at enhancing the manufacturing process for engineered T-cell receptor (TCR) therapies that target solid tumours. The collaboration will leverage Xcellbio’s unique AVATAR Foundry platform, which is